TLRs are known to be involved in the pathogenesis of the majority of neurological complications either through the activation of the inflammasome or by NF-κB-mediated transcription and translation of inflammatory mediators in several diseases, including AD, traumatic brain injury, stroke, meningitis, spinal cord injury, and MS [25,26]. This evidence concerns the gene NFKB1 and myeloid sarcoma.